title: Metabolism of murine TH 17 cells: Impact on cell fate and function.
abstract: An effective adaptive immune response relies on the ability of lymphocytes to rapidly act upon a variety of insults. In T lymphocytes, this response includes cell growth, clonal expansion, differentiation, and cytokine production, all of which place a significant energy burden on the cell. Recent evidence shows that T-cell metabolic reprogramming is an essential component of the adaptive immune response and specific metabolic pathways dictate T-cell fate decisions, including the development of TH 17 versus T regulatory (Treg) cells. TH 17 cells have garnered significant attention due to their roles in the pathology of immune-mediated inflammatory diseases. Attempts to characterize TH 17 cells have demonstrated that they are highly dynamic, adjusting their function to environmental cues, which dictate their metabolic program. In this review, we highlight recent data demonstrating the impact of cellular metabolism on the TH 17/Treg balance and present factors that mediate TH 17-cell metabolism. Some examples of these include the differential impact of the mTOR signaling complexes on T-helper-cell differentiation, hypoxia inducible factor 1 alpha (HIF1α) promotion of glycolysis to favor TH 17-cell development, and ACC1-dependent de novo fatty acid synthesis favoring TH 17-cell development over Treg cells. Finally, we discuss the potential therapeutic options and the implications of modulating TH 17-cell metabolism for the treatment of TH 17-mediated diseases.
authors.affiliation: Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, USA.
authors.forename: Ran
authors.initials: R
authors.lastname: Wang
authors.affiliation: Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, USA.
authors.forename: Laura A
authors.initials: LA
authors.lastname: Solt
mesh_terms: D000123:Acetyltransferases / Q000378:metabolism; D000818:Animals; D018791:CD4 Lymphocyte Count; D002454:Cell Differentiation / Q000276:immunology*; D049109:Cell Proliferation; D005227:Fatty Acids / Q000096:biosynthesis; D006019:Glycolysis / Q000502:physiology*; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D015398:Signal Transduction / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism; D058504:Th17 Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism*
chemical_list: D005227:Fatty Acids; C497443:Hif1a protein, mouse; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D000123:Acetyltransferases; C055210:aminoglycoside N1-acetyltransferase; C546843:mTOR protein, mouse; D058570:TOR Serine-Threonine Kinases
keywords: Fatty acid ⋅ HIF1α ⋅ Glycolysis ⋅ mTOR ⋅ RORγt ⋅ TH17/Treg balance